322 related articles for article (PubMed ID: 28009769)
1. Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
Selfani K; Soland VL; Chouinard S; Huot P
Neurologist; 2017 Jan; 22(1):24-28. PubMed ID: 28009769
[TBL] [Abstract][Full Text] [Related]
2. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 4: Case Report Data.
Macaluso M; Flynn A; Preskorn S
J Psychiatr Pract; 2016 May; 22(3):203-20. PubMed ID: 27123800
[TBL] [Abstract][Full Text] [Related]
3. High Incidence and Prevalence of Drug-Related Movement Disorders in Young Patients With Psychotic Disorders.
Mentzel TQ; Lieverse R; Bloemen O; Viechtbauer W; van Harten PN;
J Clin Psychopharmacol; 2017 Apr; 37(2):231-238. PubMed ID: 28141621
[TBL] [Abstract][Full Text] [Related]
4. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
[TBL] [Abstract][Full Text] [Related]
5. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data.
Preskorn SH; Macaluso M
J Psychiatr Pract; 2016 Mar; 22(2):117-23. PubMed ID: 27138080
[TBL] [Abstract][Full Text] [Related]
6. Covert Dyskinesia With Aripiprazole: Tip of the Iceberg? A Case Report and Literature Review.
Gomaa H; Mahgoub Y; Francis A
J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):67-70. PubMed ID: 33347026
[TBL] [Abstract][Full Text] [Related]
7. CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis.
Rudå D; Jensen KG; Decara MS; Klauber DG; Fagerlund B; Møllegaard JR; Linnet K; Werge T; Correll CU; Fink-Jensen A; Jürgens G; Pagsberg AK
J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):667-672. PubMed ID: 34735099
[TBL] [Abstract][Full Text] [Related]
8. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder: Part 1.
Preskorn S; Flynn A; Macaluso M
J Psychiatr Pract; 2015 Sep; 21(5):359-69. PubMed ID: 26348804
[TBL] [Abstract][Full Text] [Related]
9. A Review of Differences in Clinical Characteristics between Tardive Syndrome Induced or Improved by Aripiprazole Treatment.
Chen YW; Tseng PT
Acta Neurol Taiwan; 2016 Sep; 25(3):88-94. PubMed ID: 27854086
[TBL] [Abstract][Full Text] [Related]
10. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
Patra S
Curr Drug Saf; 2016; 11(1):102-3. PubMed ID: 26391425
[TBL] [Abstract][Full Text] [Related]
11. Movement disorders associated with aripiprazole use: a case series.
Hall DA; Agarwal P; Griffith A; Segro V; Seeberger LC
Int J Neurosci; 2009; 119(12):2274-9. PubMed ID: 19916856
[TBL] [Abstract][Full Text] [Related]
12. Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: a 24-week follow-up study.
Chan CH; Chan HY; Chen YC
Int Clin Psychopharmacol; 2018 May; 33(3):155-162. PubMed ID: 29324468
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and pattern of antipsychotic induced movement disorders in a tertiary care teaching hospital in India - a cross-sectional study.
Desai N; Patel PB; Shah S; Patel TK; Shah SN; Vatsala E
Int J Psychiatry Clin Pract; 2018 Jun; 22(2):101-108. PubMed ID: 28952832
[TBL] [Abstract][Full Text] [Related]
14. Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curaçao Extrapyramidal Syndromes Study XII.
Mentzel CL; Bakker PR; van Os J; Drukker M; Matroos GE; Hoek HW; Tijssen MA; van Harten PN
J Clin Psychiatry; 2017 Mar; 78(3):e279-e285. PubMed ID: 28199071
[TBL] [Abstract][Full Text] [Related]
15. Movement disorders associated with neuroleptic treatment.
Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
[TBL] [Abstract][Full Text] [Related]
16. [Aripiprazole, gambling disorder and compulsive sexuality].
Mété D; Dafreville C; Paitel V; Wind P
Encephale; 2016 Jun; 42(3):281-3. PubMed ID: 26923999
[TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia and other movement disorders secondary to aripiprazole.
Peña MS; Yaltho TC; Jankovic J
Mov Disord; 2011 Jan; 26(1):147-52. PubMed ID: 20818603
[TBL] [Abstract][Full Text] [Related]
18. [Tardive dyskinesia in a child treated with atypical antipsychotics].
Wittevrongel E; Vranken E; Pepermans A; Jaspers T
Tijdschr Psychiatr; 2020; 62(10):901-905. PubMed ID: 33184822
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of low-Dose Aripiprazole to Treat Clozapine-Associated Tardive Dystonia in a Patient with Schizophrenia].
Huh L; Lee BJ
Turk Psikiyatri Derg; 2017; 28(3):208-211. PubMed ID: 28936820
[TBL] [Abstract][Full Text] [Related]
20. Covert dyskinesia associated with aripiprazole: a case report and review of the literature.
Moseley CN; Simpson-Khanna HA; Catalano G; Catalano MC
Clin Neuropharmacol; 2013; 36(4):128-30. PubMed ID: 23860346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
